SIC
SJS Investment Consulting’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $289K | Sell |
1,556
-941
| -38% | -$175K | 0.05% | 78 |
|
2025
Q1 | $523K | Buy |
2,497
+901
| +56% | +$189K | 0.09% | 52 |
|
2024
Q4 | $284K | Sell |
1,596
-35
| -2% | -$6.22K | 0.05% | 73 |
|
2024
Q3 | $322K | Sell |
1,631
-8
| -0.5% | -$1.58K | 0.06% | 70 |
|
2024
Q2 | $281K | Hold |
1,639
| – | – | 0.05% | 69 |
|
2024
Q1 | $298K | Buy |
1,639
+76
| +5% | +$13.8K | 0.06% | 68 |
|
2023
Q4 | $242K | Sell |
1,563
-18
| -1% | -$2.79K | 0.05% | 75 |
|
2023
Q3 | $236K | Buy |
1,581
+16
| +1% | +$2.38K | 0.06% | 66 |
|
2023
Q2 | $211K | Buy |
1,565
+8
| +0.5% | +$1.08K | 0.05% | 73 |
|
2023
Q1 | $248K | Sell |
1,557
-22
| -1% | -$3.51K | 0.07% | 63 |
|
2022
Q4 | $255K | Buy |
1,579
+35
| +2% | +$5.66K | 0.08% | 64 |
|
2022
Q3 | $207K | Buy |
+1,544
| New | +$207K | 0.07% | 73 |
|
2022
Q1 | $242K | Buy |
1,494
+25
| +2% | +$4.05K | 0.07% | 79 |
|
2021
Q4 | $199K | Buy |
+1,469
| New | +$199K | 0.06% | 88 |
|